Sections

• EDITORS, AUTHORS, REVIEWERS AND AFFILIATIONS
• FOREWORD
• THE NEED FOR GUIDELINES AND THEIR IMPLEMENTATION
• CLASS OF RECOMMENDATION
• CHAPTER 1. Genetic basis, pathophysiology and diagnosis of thalassaemias
• CHAPTER 2. Blood transfusion
• CHAPTER 3. Iron overload: Pathophysiology, diagnosis and monitoring
• CHAPTER 4. Iron chelation
• CHAPTER 5. Cardiovascular disease
• CHAPTER 6. Liver disease
• CHAPTER 7. Growth abnormalities
• CHAPTER 8. Endocrine Disease
• CHAPTER 9. Infectious disease
• CHAPTER 10. Bone disease
• CHAPTER 11. Dental Care
• CHAPTER 12. Splenomegaly and splenectomy
• CHAPTER 13. Fertility and Pregnancy
• CHAPTER 14. Lifestyle and Quality of Life
• CHAPTER 15. Psychological support
• CHAPTER 16. Haematopoietic Stem Cell Transplantation for Thalassaemia
• CHAPTER 17. Gene therapy for thalassaemia
• CHAPTER 18. Novel and Emerging Therapies – Pharmaceutical approaches
• CHAPTER 19. The value of patients’ engagement
• CHAPTER 20. Multidisciplinary Care and Reference Centres in addressing haemoglobin disorders
• Monitoring - Summary Table